News

Category: BioTech

Drug for hard-to-treat lymphomas approved

Japan has become the first country to approve an anti-lymphoma drug developed following initial research from Victoria University of Wellington.   The new oral drug, called Mundesine®, treats patients with a type...

An iron-clad opportunity

Viclink startup and nanotechnology specialist Boutiq Science recently formalised its partnership with the University of South Australia (UniSA) by creating a new company, Ferronova.   The business will focus on commercialising their...

Promising Alzheimer’s research takes a step forward

Scientists from Victoria University of Wellington and the University of Liverpool have been awarded more than $850,000 to advance a potential treatment for Alzheimer’s disease.   Professor Peter Tyler (pictured, centre) and...

Avalia's Winning Ways

Victoria University of Wellington’s success in science, technology, engineering, mathematics and manufacturing (STEMM) is growing, with two winners in the 2016 Technology Valley Awards.   Victoria University biotechnology spin-out company Avalia Immunotherapies...

Viclink start-up making diagnosis easier, faster and smarter

Viclink’s new medical diagnostics start-up company, spun out of a collaboration between researchers from Victoria University of Wellington (VUW), is set to revolutionise the way medical professionals diagnose and monitor...